Stefanutti C - Search Results

1

Therapeutic Apheresis in Pregnancy: Three Differential Indications With Positive Maternal and Fetal Outcome.

Perrone G, Brunelli R, Marcoccia E, Zannini I, Candelieri M, Gozzer M, Stefanutti C. Perrone G, et al. Among authors: stefanutti c. Ther Apher Dial. 2016 Dec;20(6):677-685. doi: 10.1111/1744-9987.12422. Epub 2016 Jul 14. Ther Apher Dial. 2016. PMID: 27412826

2

Efficacy and safety of PCSK9 monoclonal antibodies.

Iqbal Z, Dhage S, Mohamad JB, Abdel-Razik A, Donn R, Malik R, Ho JH, Liu Y, Adam S, Isa B, Stefanutti C, Soran H. Iqbal Z, et al. Among authors: stefanutti c. Expert Opin Drug Saf. 2019 Dec;18(12):1191-1201. doi: 10.1080/14740338.2019.1681395. Epub 2019 Nov 20. Expert Opin Drug Saf. 2019. PMID: 31623472 Review.

3

LDL-apheresis in pediatric patients with severe hyperlipoproteinemia.

Stefanutti C, Vivenzio A, Colombo C, Di Giacomo S, Mazzarella B, Berni A, Nigri A, Koga N. Stefanutti C, et al. J Clin Apher. 1995;10(2):101-2. doi: 10.1002/jca.2920100210. J Clin Apher. 1995. PMID: 7592515 No abstract available.

4

LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.

Stefanutti C, Notarbartolo A, Colloridi V, Nigri A, Vivenzio A, Bertolini S, Bosco G, Berni A, Di Giacomo S, Mazzarella B. Stefanutti C, et al. Artif Organs. 1997 Oct;21(10):1126-7. doi: 10.1111/j.1525-1594.1997.tb00453.x. Artif Organs. 1997. PMID: 9335372

5

[LDL-apheresis: current status].

Stefanutti C, Vivenzio A, Lucani G, Di Giacomo S. Stefanutti C, et al. Clin Ter. 2001 Jan-Feb;152(1):65-9. Clin Ter. 2001. PMID: 11382172 Review. Italian.

6

Low-density lipoprotein apheresis in a patient aged 3.5 years.

Stefanutti C, Di Giacomo S, Vivenzio A, Colloridi V, Bosco G, Berni A, Rabbone I, Cerutti F, Bertolini S. Stefanutti C, et al. Acta Paediatr. 2001 Jun;90(6):694-701. doi: 10.1080/080352501750258793. Acta Paediatr. 2001. PMID: 11440106

7

DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulation.

Stefanutti C, Di Giacomo S, Di Caro M, Vivenzio A, Musca A. Stefanutti C, et al. Ther Apher. 2001 Oct;5(5):364-71. doi: 10.1046/j.1526-0968.2001.00373.x. Ther Apher. 2001. PMID: 11778921

8

Immunoadsorption apheresis (Selesorb) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia.

Stefanutti C, Di Giacomo S, Mareri M, De Lorenzo F, D'Alessandri G, Angelico F, Bucci A, Musca A, Mammarella A. Stefanutti C, et al. Transfus Apher Sci. 2003 Jun;28(3):207-14. doi: 10.1016/s1473-0502(03)00055-7. Transfus Apher Sci. 2003. PMID: 12725944 Clinical Trial.

9

Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks.

Stefanutti C, Lanti A, Di Giacomo S, Mareri M, De Lorenzo F, Landolfo A, Isacchi G. Stefanutti C, et al. Transfus Apher Sci. 2004 Aug;31(1):3-10. doi: 10.1016/j.transci.2004.01.010. Transfus Apher Sci. 2004. PMID: 15294188

10

Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone.

Stefanutti C, Vivenzio A, Di Giacomo S, Mareri M, Ceccarelli F, Valesini G. Stefanutti C, et al. BioDrugs. 2005;19(2):129-33. doi: 10.2165/00063030-200519020-00004. BioDrugs. 2005. PMID: 15807630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results